女性生殖因素、外源性激素使用与慢性肾脏病及终末期肾病发病风险
纳入260 108名无 prevalent CKD 和 ESRD 的女性,中位随访约12.5年,期间发生8766例CKD和554例ESRD。首次活产年龄较轻、50岁前子宫切除或双侧卵巢切除、45岁前绝经、50岁前启动绝经激素治疗与CKD风险升高相关,与ESRD关系基本一致。绝经年龄每延迟5年,CKD风险降低11%(HR=0.89;95%CI 0.87-0.91),ESRD风险降低13%(HR=0.87;95%CI 0.79-0.95);启动绝经激素治疗每延迟5年,CKD风险降低13%(HR=0.87;95%CI 0.84-0.90),ESRD风险降低15%(HR=0.85;95%CI 0.73-0.99)。
要点
- 首次活产年龄较轻、50岁前子宫切除或双侧卵巢切除、45岁前绝经、50岁前启动绝经激素治疗与CKD风险升高相关。
- 绝经年龄每延迟5年,CKD风险降低11%(HR=0.89;95%CI 0.87-0.91),ESRD风险降低13%(HR=0.87;95%CI 0.79-0.95)。
- 启动绝经激素治疗每延迟5年,CKD风险降低13%(HR=0.87;95%CI 0.84-0.90),ESRD风险降低15%(HR=0.85;95%CI 0.73-0.99)。
核心结论
- 反映内源性雌激素累积暴露时间较短或外源性激素暴露过早的若干生殖特征与女性CKD和ESRD风险升高相关,支持女性激素在肾脏病理生理中的潜在作用。
研究设计与样本
- 纳入260 108名无 prevalent CKD 和 ESRD 的女性,评估多种生殖因素及外源性激素使用与CKD和ESRD发病的关系,并对潜在混杂因素进行多变量调整。
主要发现
- 中位随访约12.5年期间,共识别8766例CKD和554例ESRD。
- 首次活产年龄较轻、50岁前子宫切除或双侧卵巢切除、45岁前绝经、50岁前启动绝经激素治疗与CKD风险升高相关;这些因素与ESRD的关系总体与CKD一致。
- 绝经年龄每增加5年,CKD风险降低11%(HR=0.89;95%CI 0.87-0.91),ESRD风险降低13%(HR=0.87;95%CI 0.79-0.95)。
- 启动绝经激素治疗每延迟5年,CKD风险降低13%(HR=0.87;95%CI 0.84-0.90),ESRD风险降低15%(HR=0.85;95%CI 0.73-0.99)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Younger women have a slower progressive loss of kidney function than age-matched men and the sex advantage diminishes after menopause, suggesting a role for female hormones in the development of kidney diseases. OBJECTIVE: To examine the relationships of numerous reproductive factors and exogenous hormone use with long-term risk of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in women. METHODS: A total of 260 108 women without prevalent CKD and ESRD were included. The relationships of various reproductive factors and exogenous hormone use with incident CKD and ESRD were assessed, with multivariable adjustment for potential confounders. RESULTS: During a median of ∼12.5 years of follow-up, 8766 CKD and 554 ESRD cases were identified. Younger age at first live birth, hysterectomy or bilateral oophorectomy before age 50 years, menopausal before age 45 years, and menopausal hormone therapy initiated before age 50 years was associated with a higher risk of CKD. The relationships of these factors with ESRD were generally consistent with those for CKD. Each 5-year increment in menopausal age was associated with an 11% lower risk of CKD (hazard ratio [HR] = 0.89; 95% CI, 0.87-0.91) and a 13% lower risk of ESRD (HR = 0.87; 95% CI, 0.79-0.95). Each 5-year delay in starting menopausal hormone therapy was associated with a 13% lower risk of CKD (HR = 0.87; 95% CI, 0.84-0.90) and a 15% lower risk of ESRD (HR = 0.85; 95% CI, 0.73-0.99). CONCLUSIONS: Several reproductive characteristics reflecting shorter cumulative exposure to endogenous estrogen or premature exposure to exogenous hormones are associated with a greater risk of CKD and ESRD in women, supporting a potential role of female hormones in renal pathophysiology.
引用
- Han WW, Miao MY, Lyu JQ, et al. Female Reproductive Factors, Exogenous Hormone use, and Incident Chronic Kidney Disease and end-stage Renal Disease. J Clin Endocrinol Metab. 2025. PMID: 38829052. doi:10.1210/clinem/dgae374
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。